This is consistent with our CRISPR screen results, showing that BRCA2 was identified as one of the top hits in TP53-mutated DU145 cells, while many of the canonical HRR genes (including Fanconi anemia genes) were not negatively selected. This evidence concerns the gene TP53 and Fanconi anemia.